BofA Securities Moves GlaxoSmithKline (GSK:LN) (GSK) at Underperform

December 5, 2022 5:47 AM

(Updated - December 5, 2022 5:54 AM EST)

BofA Securities analyst Graham Parry downgrades GlaxoSmithKline (GSK:LN) (NYSE: GSK) Underperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found